{
    "Orphapacket": {
        "ORPHApacketId": "86904",
        "creationDate": "2021-08-17 17:32:38",
        "version": "1.3.7 / 4.1.7 [2020-12-03] (orientdb version)",
        "copyright": "Orphanet (c) 2021",
        "ORPHAcode": "86904",
        "Label": "Methotrexate-associated lymphoproliferative disorders",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_86904",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "MTX-LPD"
            },
            {
                "Synonym": "MTX-associated lymphoproliferative disorders"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Methotrexate-associated lymphoproliferative disorders are rare immunodeficiency-associated lymphoproliferative diseases characterized by lymphoid proliferation or lymphomas (large B-cell lymphoma T-cell lymphoma Hodgkin lymphoma reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "98290",
                        "Label": "Immunodeficiency-associated lymphoproliferative disease"
                    }
                ]
            }
        ]
    }
}